Background/Aims: The elaborate structure of the extracellular matrix (ECM) and the appropriate surface glycoforms upon it are indispensable to CD4 + T cell regulation. Methods: To explore the effects of Glcα1,2Galβ1 glycosylation mediated by GLT25D2 (Colgalt2) for CD4 + T cell regulation, we prepared C57BL/6J Glt25d2 −/− mice. In the induction of hepatitis, after concanavalin A (Con A) challenge for 6, 12, and 24 h, more extensive parenchymal injury was noted in Glt25d2 −/− mice than in wild-type (WT) mice at 12 h. Immunohistochemistry and laser scanning confocal microscopy were used to detect GLT25D2 expression, and subsets of CD4+T cells was analyzed by flow cytometry. A total of 26 cytokines in serum samples were determined using Luminex technology. Results: The trend in liver injury score variation was consistent with serum alanine aminotransferase and aspartate aminotransferase levels. The levels of interleukin 4 (IL-4), IL-1β, IL-9, and several chemokines such as macrophage inflammatory protein-2, eotaxin, and growth-related oncogene α were significantly increased in Glt25d2 −/− mice compared with WT mice after Con A challenge. A further phenotype analysis of primary Glt25d2 −/− CD4 + T cells showed that Glt25d2 knockout increased the frequency of the CD25 + CD69 − subset but decreased the frequency of the CD25 − CD69 + subset after Con A challenge for 6, 12, and 24 h compared with those of WT CD4 + T cells. Activation-induced apoptosis was also significantly increased in Glt25d2 −/− CD4 + T cells after Con A challenge compared with WT CD4 + T cells. Lectin microarray hybridization showed that Glt25d2 knockout increased the binding activity of Narcissus pseudonarcissus lectin to CD4 + T cells but
Introduction
Over the past half century, extracellular matrix (ECM) research has shown that matrix components play a fundamental role in immunity, including in immune cell development, effector regulation, and ligand-receptor interactions [1] [2] [3] . The function of T lymphocytes involved in an immune response is dependent on the precise matrix structure of the ECM. The dynamic variation of the ECM is indispensable for the migration and activation of effector T cells. Some ECM components, such as proteoglycans, can also act as signaling molecules, endogenous ligands of Toll-like receptors, activators of the innate immune response, and mediate activators of the adaptive immune response during inflammation [4, 5] . The ECM can also modify major histocompatibility complex class II expression in the pathological state [6] .
Collagen proteins are the most abundant components in the ECM, constituting >30% of the total protein mass in multicellular organisms. Therefore, genetic defects of collagen formation affect almost every organ system and tissue throughout the body [7] . Among the genomes of vertebrates and higher invertebrates, 28 distinct collagen glycoproteins are encoded by at least 45 genes [8] . The primary structure of a collagen protein consists of GlyXaa-Yaa repeats and forms a left-handed polyproline II-like helix. Three glycopeptide chains align with an offset right-handed superhelix. Each peptide chain has at least one collagenous and one non-collagenous domain, variations of which depend on the specific collagen type [9] .
After initiating translation, the pro-collagen peptide translocating into the endoplasmic reticulum (ER) is co-translationally modified by hydroxylation and glycosylation of lysine and hydroxylysine, respectively. Mature collagen molecules are modified by Glcα1, 2Galβ1-glycan on the hydroxylysine residue. The glycosylated levels of collagen proteins vary among tissues and organs. Since the first report nearly 60 years ago showed that collagen contains a galactose or glucosylgalactose O-glycosidically linked to the hydroxylysine residue, it was of interest to explore which glycosyltransferase plays a critical role in this glycosylation process [10, 11] . At the start of this century, lysyl hydroxylase 3 (EC 1.14.11.4) was found to possess the activities of galactosyltransferase (EC 2.4.1.50) and glucosyltransferase (EC 2.4.1.66) [12] . Schegg and colleagues recently reported that human collagen glycosylation is initiated by two β(1-O)galactosyltransferases in vitro, specifically GLT25D1 (Colgalt1) and GLT25D2 (Colgalt2) [13] .
In the ECM, the elaborate collagen structure is critical for coordinating lymphocyte homing, differentiation, and activation, as well as targeting migration [14, 15] . More importantly, some glycan components in the ECM may enhance T cell activation and trigger autoimmune inflammation [16] . Some collagen molecules, such as elastin peptides, can directly regulate immune responses in aging and age-related diseases [17] . In fact, peripheral CD8 + T cell activation was directly triggered by the ECM, as seen for those cells from mesenteric lymph nodes in vivo [18] . These results suggested that the glycan structure of collagen plays an important role in T lymphocyte regulation, but as far as we have seen, no relevant data are available. Consequently, the elucidation of the interaction between collagen glycosylation and lymphocyte regulation is essential for generating effective immunotherapies.
Many components of the ECM are correlated with CD4 + T lymphocyte regulation, such as laminins [19] , proteoglycan aggrecans [20] , and integrin [21, 22] . The co-culturing of CD4 + T cells with fibroblasts significantly increased the secretion of IL-17 and other cytokines [23] . These results suggested that the ECM and its elaborate construction is indispensable to the functional regulation of CD4 + T lymphocytes. As a major component of the ECM, its extent and pattern of glycosylation directly regulate cross-link maturation in fibrillar collagen [24, 25] . More importantly, almost all ECM components are glycoproteins since these components require trafficking from a secretory pathway (from the ER to the Golgi complex) to the ECM. CD4 + T regulation may be dependent on collagen glycosylation to some degree. As far as we have seen, there is currently no evidence available to answer this question.
To address this question, we recently prepared a Glt25d2-knockout (Glt25d2 −/− ) mouse model [26] . The intravenous injection of concanavalin A (Con A) is a widely used model for acute immune-mediated hepatitis in mice [27] . Since CD4 + T lymphocytes as well as NKT cells are the major effector cells involved in Con A hepatitis [28] , the Con A-induced hepatitis model was chosen to elucidate the role of CD4 + T cells in Glt25d2 −/− mice. CD25 and CD69 are activation markers of T lymphocytes [29] . The emergence of CD25 molecules can occur if CD4 + T cells are activated and proliferating [30] . As the best-characterized populations of regulatory T cells, CD4 +
CD25
+ T cells have important roles in maintaining normal homeostasis and play a crucial role in infectious and degenerative diseases [31] .
Our present results suggest that Glt25d2 knockout regulates the subset frequency of CD4 + T cells and is involved in the pathogenesis of Con A-induced hepatitis.
Materials and Methods

Preparation of Glt25d2
−/− mice and ethics statement To elucidate the role of GLT25D2 in liver injury, we recently prepared Glt25d2 −/− mice using a genetargeting method [26] . The sense primer (loxp-F) 5′-ATGTCCTGTCTAGTGTGGTCC-3′ and antisense primer (Loxp-R) 5′-agggagttgtgcgaatctat-3′ were used to genotype the wild-type (WT) and Glt25d2 −/− mice. Western blotting was used to further confirm Glt25d2 knockout (polyclonal anti-GLT25D2; Abcam, Cambridge, UK).
The experimental mice were raised in the Animal Center of Peking University Health Science Center according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. This study was approved by the Experimental Animal Care and Use Committee of Peking University Health Science Center.
Animals and hepatitis model
To create the Con A-induced hepatitis model, male mice (6-8 weeks old) were used in this experiment [27] . Specific-pathogen-free WT (Glt25d2 +/+ ) C57BL/6J mice (Animal Center of Peking University Health Science Center, Beijing, China) were used as control animals. Each was maintained in a specific-pathogenfree condition at the Animal Center of Peking University Health Science Center. All experimental mice were housed under standard conditions (22-24°C) with a light-dark cycle of 12:12 h. Sterile water and food were available ad libitum. The hepatitis model was induced by an intravenous injection of 10 mg/kg Con A (SigmaAldrich, St. Louis, MO) and the liver injury was assessed before and 6, 12, and 24 h after Con A administration. The liver injury was assessed as serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). The injury score was used to evaluate the hepatic tissue staging as previously reported [32] . The study design is shown in Fig. 1 .
Immunohistochemistry and laser scanning confocal microscopy
After the mice were sacrificed, the liver and spleen tissues were obtained at different time points after Con A injection. The tissues were fixed with 10% formaldehyde, embedded in paraffin, and cut into 3-to 5-μm sections. Hematoxylin and eosin (H&E) staining was used to evaluate liver injury grade. After antigen retrieval was completed in sodium citrate buffer (pH 6.0 for 10 min), the endogenous peroxidase was blocked for 5 min. Sections were incubated for 1 h at room temperature with anti-GLT25D2 antibody (1:500). After incubation with the secondary horseradish peroxidase-conjugated immunoglobulin G, DAB chromogen was used to detect GLT25D2 expression in the hepatic and splenic tissues. We subcloned the coding sequence of Glt25d2 into the pDSRED-N1 plasmid. The pDSRED-Glt25d2-N1 plasmid was then transfected into HSC-T6 cells to express GLT25D2 recombinant protein with red fluorescence. The coding sequence of the ER-Golgi intermediate compartment 53 (ERGIC53) protein [33, 34] was subcloned into the pEGFP-C1 plasmid to construct the pEGFP-ERgic53-C1 plasmid, which expresses recombinant ERGIC53 protein with green fluorescence. DAPI staining was performed 48 h after co-transfection of the pDSRED-Glt25d2-N1 and pEGFP-ERgic53-C1 plasmids into HSC-T6 cells. Confocal laser scanning microscopy (Zeiss LSM 510, Oberkochen, Germany) was used to analyze the GLT25D2 and ERGIC53 expression in the HSC-T6 cells.
Flow cytometry analysis of CD4
+ subsets in peripheral blood mononuclear cells and splenocytes To detect surface markers of CD4 + T cells, peripheral blood mononuclear cells and splenocytes were stained with CD4-APC, CD8-perCP, CD25-PE, and CD69-FITC antibodies (eBioscience, San Diego, CA) and incubated for 20 min at 4°C in the dark. After washing, we performed flow cytometry analysis (FACSCalibur flow cytometer; BD Biosciences, San Jose, CA) of the CD4 + T cell subsets. At least 10, 000 live events were accumulated through forward-and side-scatter parameters. CellQuest Pro software (BD Biosciences) was used to analyze the flow cytometry data.
Primary CD4 + T cell proliferation and apoptosis in vitro Splenocytes were harvested from the WT and Glt25d2
−/− mice by dissociation through a 0.45-μm wire mesh. After lysing erythrocytes using ammonium chloride, the cells were subsequently resuspended in complete RPMI 1640 media containing 10% fetal calf serum, l-glutamine, penicillin, and streptomycin. To isolate the CD4 + T cells, the magnetic bead sorting technique (EasySep Mouse CD4 + T Cell Isolation Kit; Miltenyi Biotec, Bergisch Gladbach, Germany) was used. Briefly, splenocytes were incubated with anti-CD4 microbeads for 15 min at 4°C following the manufacturer's instructions. After washing with PBEB buffer (phosphate buffered saline [PBS], 0.5% bovine serum albumin, 5 mM ethylenediaminetetraacetic acid), the CD4 + T cells were eluted from the LS columns and resuspended in RPMI 1640 media. After culturing in RPMI 1640 media for 12 h, the CD4 + T cells were treated with Con A (5 µg/mL) for another 6, 12, or 24 h. For the subset analysis, CD4 + T cells from the WT and Glt25d2 −/− mice were incubated with fluorescently tagged antibodies against CD4, CD8, CD25, and CD69 (eBioscience) for 30 min at room temperature in the dark. Before the analysis, the stained CD4 + T cells were washed with cold PBS. For the apoptosis evaluation, the CD4 + T cells from the WT and Glt25d2 −/− mice were incubated in medium containing Con A for 0, 6, 12, or 24 h. The cells were labeled with an apoptosis marker (Annexin V, 7-AAD) for the subset analysis. Briefly, after being labeled with CD4 antibody, the cells were washed with PBS and resuspended in binding buffer. After anti-Annexin V fluorescently tagged antibody and 7-AAD were added, the CD4 + T cells were incubated for 10 min in the dark at 37°C. Apoptosis was calculated as the percentage of 7-AAD + and Annexin V + cells.
Cytokine determination
A total of 26 cytokines in serum samples were determined using Luminex technology with Milliplex detection kits (Millipore, Burlington, MA) according to the manufacturer's protocols. Those cytokines included interleukins and nine chemokines. 
Lectin microarray and hybridization
The lectin microarray was prepared as previously described [35, 36] . Briefly, lectins (Vector Laboratories, Inc., Burlingame, CA) (Table 1) were dissolved in spotting solution at a concentration of 1 mg/ mL (Sambucus nigra leptin, MAL-I, and MAL-II) or 0.5 mg/mL (other lectins) and spotted in duplicate onto a 3-glycidoxypropyltrimethoxysilane glass slide using a microarray printing robot (MicroGridII; BioRobotics Ltd., Cambridge, UK). After being spotted, washed, and incubated, the slides were blocked with 1% bovine serum albumin. Purified CD4 + T cells from the spleens of WT and Glt25d2 −/− mice were cultured in RPMI 1640 media. Before and after Con A treatment for 6, 12, or 24 h, the harvested CD4 + T cells were suspended in PBS and allowed to bind to lectin microarrays at 37°C for 30 min. The unbound CD4 + T cells were washed with cold PBS. The bound CD4
+ T cells immobilized on the glass slides were stained with H&E and observed by microscopy.
Statistical analysis
The quantitative results are represented as the mean ± SEM. Intergroup differences were tested using Student's t test or the Mann-Whitney U test. Differences among multiple groups were analyzed using oneway analysis of variance. Statistical significance was defined as values of P < 0.05. These analyses were performed using GraphPad Prism version 5.01 software.
Results
GLT25D2 expressed in hepatic and splenic tissues Using our previously prepared Glt25d2
−/− mice, we first confirmed the genotype and phenotype using polymerase chain reaction ( Fig. 2A ) and western blotting (Fig. 2B) , respectively. We further evaluated GLT25D2 expression in the hepatic and splenic tissues of WT and Glt25d2 −/− mice by immunohistochemical (IHC) staining. As we speculated, there was no GLT25D2 protein expression in the tissues of the Glt25d2 −/− mice; however, IHC staining revealed that the GLT25D2 protein was expressed in the hepatic and splenic tissues of WT mice ( Fig. 2C-E) .
GLT25D2 expressed in hepatic and splenic tissues
The C-terminus of GLT25D2 contains the RDEL motif, an ER retrieval signal, suggesting that it is a resident protein in the ER according to a recent report [36] . The confocal laser scanning microscopy images show that GLT25D2 protein and ERGIC53 protein were colocalized in the ER (Fig. 2F) .
Glt25d2 knockout aggravates liver injury
We first determined whether GLT25D2 was involved in Con A-induced liver injury. Con A (10 mg/kg) was injected into healthy WT mice and Glt25d2 −/− mice to prepare the Con Ainduced hepatitis model. H&E staining showed that Con A administration resulted in more extensive hepatocellular damage in Glt25d2 −/− mice than in WT mice, as represented by the presence of a severely collapsing liver plate (Fig. 3) . The liver injury scores of Glt25d2 −/− mice were increased after Con A challenge for 12 h (3.5 ± 0.45; P = 0.02) compared with those of Glt25d2 −/− mice after 12 h (2.88 ± 0.44). However, there was no difference in injury scores between Glt25d2 −/− and WT mice after Con A challenge for 6 or 24 h (1.71 ± 0.49, P = 0.32; 3.58 ± 0.49 vs 3.50 ± 0.44, P = 0.71, respectively). This variation trend was consistent with the serum ALT and AST levels. Although those mice were raised in the same conditions, the ALT levels (58.83 ± 15.28 U/L) of the Glt25d2 −/− mice were significantly higher than those of the WT mice (43.38 ± 10.54 U/L, P = 0.04) at baseline. After Con A administration for 6 h (6738.0 ± 3524.0 U/L vs 2101 ± 1811 U/L, P = 0.01) or 12 h (15060.0 ± 8052.0 U/L vs 7041.0 ± 2056 U/L, P = 0.02), this difference was more significant (Fig. 3) . The same variation trend was also observed in serum AST levels before and after Con A challenge between WT and Glt25d2 −/− mice (Fig. 3) .
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Fig. 2.
Immunohistochemical staining of GLT25D2 expression in hepatic and splenic tissues. A, GLT25D2 protein in the hepatic tissue of wild-type mice was mainly expressed in the interstitial region. B, Major expression was seen in the germinal center of splenic tissue, whereas no expression was seen in the hepatic and splenic tissues of Glt25d2 −/− mice. C, GLT25D2 protein was expressed in the hepatic tissues of WT mice. D, GLT25D2 protein was expressed in the splenic tissues of WT mice. E, Isotype control liver and spleen tissue. F, Confocal laser scanning microscopy images show that GLT25D2 and ERGIC53 proteins were colocalized in the endoplasmic reticulum. 
Different cytokine profiles between WT and Glt25d2
−/− mice To characterize the inflammatory response more completely between WT and Glt25d2 −/− mice, we performed Luminex analysis of the serum. After Con A challenge for 6 h (25.79 ± 4.32 pg/mL) or 12 h (18.43 ± 4.41 pg/mL), the serum IL-1β levels of the Glt25d2 −/− mice were markedly increased compared with those of the WT mice (17.5 ± 3.9 pg/mL, P = 0.002; and 10.43 ± 2.79 pg/mL, P = 0.003). After Con A challenge for 6, 12, or 24 h, the levels of IL-4, IL-6, and IL-9 were also significantly increased in Glt25d2 −/− mice compared with those in WT mice (Fig. 4) . This trend was also observed with some chemokines, including macrophage inflammatory protein 2 (MIP-2), eotaxin, and growth-related oncogene α (GROα) (Fig. 4) . The notable result is the serum IL-9 level. After Con A administration for 6, 12, and 24 h, the serum IL-9 level was decreased in WT mice but significantly increased in Glt25d2 −/− mice after Con A challenge for 12 h (19.09 ± 11.54 pg/mL vs 7.82 ± 5.26 pg/mL, P = 0.02). No differences in serum levels of other cytokines were observed between WT and Glt25d2 −/− mice, such as IL-17, IL-23, IL-27, IL 12p70, MCP-3, MIP-1a, MIP-1b, and RANTES (data not shown).
Phenotype analysis of blood and splenic subsets of CD4 + T cells To investigate whether proliferation in CD4
+ T cell subsets plays a role in Con A-induced liver injury, we studied the characteristics of CD4 + T cell subsets of Con A-challenged mice. Con A administration induced a significant decrease in the frequency of the CD25 + CD69 + subset in the blood of Glt25d2 −/− mice (17.85% ± 5.52% vs 33.24% ± 3.96%, P < 0.0001) 12
Fig. 3. Liver injury score and serum biochemical analysis. A, Hematoxylin and eosin staining of hepatic tissue (×200).
After concanavalin A (Con A) administration for 6, 12, or 24 h, centrilobular hemorrhagic necrosis was seen in the hepatic tissue. The injury score for lobular inflammation was as reported previously [50] . B, Compared with tissues of wild-type mice, more intensive necrosis was visible in the Glt25d2 −/− mouse hepatic tissue after Con A challenge for 12 h. C, D, Alanine aminotransferase and aspartate transferase levels varied before and after Con A challenge for 0, 6, 12, or 24 h (*P<0.05; **P<0.01). + subset was markedly increased at 24 h (13.02% ± 2.06% vs 7.17% ± 3.55%, P = 0.01) compared with those of WT mice (Fig.  5) . Interestingly, the increased frequency of the CD25 +
CD69
− subset was only seen in the spleens of Glt25d2 −/− mice after Con A challenge for 12 h (13.52% ± 2.88% vs 9.97% ± 1.38%, P = 0.007) and 24 h (15.90% ± 3.26% vs 7.60% ± 2.94%, P = 0.0009); the frequency of the 
CD25
− CD69 + subset in splenocytes was significantly increased after Con A challenge for 12 h (7.41% ± 0.96% vs 4.00% ± 2.02%, P = 0.001) compared with those in WT mice (Fig. 6) . The other notable result was that the subset frequency of Glt25d2 −/− CD4 + T cells was significantly different from that in WT CD4
+ T cells at baseline (before Con A challenge).
Glt25d2 knockout increased frequency of the CD25 + CD69
− subset but decreased frequency of the CD25 − CD69 + subset in primary CD4 + T cells To further define the functional role of GLT25D2 in Con A-induced hepatitis, the CD4 + T cells were isolated from splenocytes and challenged with Con A (5 μg/mL) for 0, 6, 12, or 24 h. The frequency of the CD25 +
CD69
− subset was significantly increased in Glt25d2 −/− CD4 + T cells after Con A challenge for 0 h (8.94% ± 0.37% vs 4.75% ± 0.38%, P < 0.0001), 6 h (8.85% ± 0.56% vs 3.49% ± 0.36%, P < 0.0001), 12 h (9.97% ± 0.19% vs 5.05% ± 1.13%, P < 0.0001), or 24 h (16.78% ± 0.41% vs 11.14% ± 0.47%, P < 0.0001) compared with those in WT CD4 + T cells. However, the frequency of the CD25 − CD69 + subset was markedly decreased in Glt25d2 −/− CD4 + T cells after Con A challenge for 6 h (11.04% ± 0.69% vs 28.77% ± 1.56%, P < 0.0001), 12 h (6.27% ± 0.27% vs 11.05% ± 0.96%, P < 0.0001), or 24 h (4.42% ± 0.20% vs 6.50% ± 0.44%, P < 0.0001) compared with those in WT CD4 + T cells (Fig. 7) .
Activation-induced apoptosis increased in Glt25d2
−/− CD4 + T cells Since the proper function of T lymphocytes is correlated with glycosylation status, we also determined whether the apoptosis of CD4 + T cells changed after Glt25d2 knockout. We observed the apoptosis rate of primary CD4 + T cells from WT and Glt25d2 −/− mice after challenge with Con A (5 μg/mL) for 0, 6, 12, or 24 h. Subsequently, the cells were stained with fluorescently tagged annexin V antibody and 7-AAD. As expected, the activationinduced apoptosis was significantly increased in CD4 + T cells from Glt25d2 −/− mice after Con A challenge for 6 h (24.62% ± 4.00% vs 16.88% ± 5.65%, P = 0.0085), 12 h (13.02% ± 1.60% vs 1.49% ± 1.24%, P < 0.0001), and 24 h (4.70% ± 1.86% vs 0.59% ± 0.42%, P < 0.0001) compared with those in CD4 + T cells from WT mice (Fig. 8) . 
CD4
+ T cells (Fig. 9) . Glt25d2 knockout significantly increased the binding activities of several lectins. The Wisteria floribunda lectin (WFL)-, hippeastrum hybrid lectin (HHL)-, wheat germ agglutinin, Galanthus nivalis lectin (GNL)-, and Narcissus pseudonarcissus leptin (NPL)-binding activities were only observed in Glt25d2 −/− CD4 + T cells; in contrast, the MPLand Erythrina cristagalli lectin (ECA)-binding activities were found only in WT CD4 + T cells. Glt25d2 knockout seemed to have no significant effect on the binding activities of soybean agglutinin lectin, Maackia amurensis leucoagglutinin 1 (MAL1), Amaranthus caudatus lectin (ACL), or jackfruit lectin of CD4 + T cells under normal conditions (Table 2 ). Since glycoform reconstruction occurs during T lymphocyte activation, we also determined the surface glycoform variation of CD4 + T cells for Con A-induced activation at 6, 12, and 24 h. Table 2 shows that Glt25d2 knockout increased binding of NPL to CD4 + T cells, whereas ACL-binding activity was lost. The binding activities of several lectins, namely, MAL1, WFA, MPL, and ECA, were lost during Con A stimulation, whereas those of HHL and GNL were increased irrespective of CD4 + T cell genotype (WT vs Glt25d2 −/− ) ( Table 2) . MPL  +  --+  ----ECA  +  -----+  -WFA  -+  ------HHL  -+  +  +  +  +  +  +  WGA  -+  ----+  -GNL  -+  +  +  +  +  +  +  NPL  -+  -+  ---+  SBA  +  +  +  +  +  -+  +  MAL-I  +  +  ------ 
Discussion
Collagen structure is critical to CD4 + T cell regulation [37] , but the effect of collagen glycosylation on CD4 + T cell regulation remains unknown (14, 17) . Using our Glt25d2
−/− mouse model, we found that Glt25d2 knockout regulated the frequency of CD4 + T cell subsets involved in Con A-induced hepatitis.
Glycosylation of the collagen protein was discovered nearly 60 years ago (10) , and only recently were three gene products considered candidate glycosyltransferases, namely, lysyl hydroxylase 3 (12), GLT25D1, and GLT25D2 [13, 38, 39] . In one of these studies, GLT25D2 was shown to mediate Glcα1, 2Galβ1 glycosylation of hydroxylysine in collagen proteins (13) .
Using our Glt25d2
−/− mouse model, we found that Glt25d2 knockout directly aggravated liver injury and increased the inflammatory response after Con A challenge. Based on the present data and recent results, IL-4, IL-6, IL-1β, and IL-9 may complicate this process [40, 41] . Some chemokines, such as MIP-2, eotaxin, and GROα, were also significantly increased in Glt25d2 −/− mice after Con A challenge compared with those in WT mice. The above results suggested that Glt25d2 knockout may result in an abnormal chemotactic response to inflammatory cells.
Based on a recent report, GLT25D2 is a glycotransferase that mediates Glcα1, 2Galβ1 glycosylation of hydroxylysine in collagen and is involved in collagenous fibrils assembling into collagen fibers [13] . Since many proteins contain collagen domains and are involved in T cell regulation, as recent reports stated [42] , we considered that GLT25D2 could mediate Glcα1, 2Galβ1 glycosylation of other collagen-like proteins in primary CD4 + T cells in vitro and play a role in CD4 + T cell regulatory processes such as proliferation and apoptosis. CD4
+ T cells are a novel subset of regulatory T cells that suppress T cell proliferation [43] and play a role in anti-graft-versus-host disease in humans [44] . We recently also found that the CD25 − CD69
+ subset of CD4 + T cells is also involved in Con A-induced hepatitis [45] . To put our data in a wider context, the relative decrease in the CD25 −
CD69
+ subset suggested that the CD4 + regulatory T cells may be partly suppressed in Glt25d2 −/− mice. Our present results demonstrate for the first time that glycosylation mediated by GLT25D2 regulates the subset frequency of CD4 + T cells. However, the molecular mechanisms of how surface glycoform changes influence the subset differentiation of CD4 + T cells requires elucidation. As shown in a previous report [35] and confirmed here, altering cell surface glycan repertoires leads to different subset differentiation of CD4 + T cells. Different from hyposialylation (Cmah −/− mice) leading to T lymphocyte proliferation and activation [46] , inhibiting Glcα1, 2Galβ1 glycosylation (Glt25d2 −/− mice) resulted in a different subset of CD4 + T cells. As described above, many cell surface proteins may also be targets of GLT25D2 since they contain a collagen domain, such as mannan-binding lectin, which directly regulates T cell proliferation [47] . Therefore, we speculated that the differences in the lectin-binding signature resulted from the Glt25d2 knockout in vitro. Glt25d2 knockout increased the binding activity of NPL to CD4 + T cells, whereas ACL-binding activity was lost. This result suggests that other receptor substrates of GLT25D2 may exist in CD4 + T cells since NPL and ACL mainly recognize the terminal mannose Galβ1, 3GalNAc of cell surface glycans.
In contrast to findings of a previous study in human tissue [21] , the present data show that GLT25D2 is broadly expressed in the spleen, thymus, and other tissues of mice. This expression difference may be due to species differences. The major limitation of the present study is that all the data are based on primary CD4 + T cells in vitro. Glt25d2 knockout may lead to more complicated subset differentiation of CD4 + T cells in vivo. Based on a recent report, GLT25D1 may partly play a compensatory role in collagen glycosylation after Glt25d2 knockout [48] . The exact role of Glcα1, 2Galβ1 glycosylation in collagen secretion and CD4 + T differentiation remains to be clarified.
Since the collagen glycosylation mediated by GLT25D2 (and GLT25D1) is initiated in the ER, we speculated that CD4 + T cell regulation by GLT25D2 may be via two major pathways: (i) directly modifying collagen and influencing ECM structure; and (ii) modifying some proteins containing collagen domains that are located on the surface of CD4 + T cells, such as C-type lectins [49] , playing a very important indirect role in CD4 + T cell regulation. The present results suggest that collagen glycosylation mediated by GLT25D2 may be involved in regulating proliferation of CD4 + T cell subsets and correlated with the pathogenesis of immune hepatitis. Collagen Glcα1, 2Galβ1 glycosylation mediated by GLT25D2 may be a new target of drug development for immune regulation and protection against liver injury.
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